Business Combinations - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
|---|---|---|---|---|---|
May 01, 2025 |
Apr. 30, 2025 |
Feb. 07, 2025 |
Apr. 30, 2026 |
Jan. 31, 2026 |
|
| Business Combination [Line Items] | |||||
| Contingent consideration | $ 3,275 | $ 9,700 | |||
| Measurement period adjustments | $ 147 | ||||
| Restricted Stock Units (RSUs) | |||||
| Business Combination [Line Items] | |||||
| Granted (in shares) | 351,006 | ||||
| Sandbox | |||||
| Business Combination [Line Items] | |||||
| Transaction costs | $ 1,400 | ||||
| Cash consideration to members | $ 53,500 | 53,488 | |||
| Contingent consideration | 8,100 | $ 500 | |||
| Present value | $ 10,000 | ||||
| Measurement period adjustments | $ 100 | ||||
| Decrease goodwill | $ 100 | ||||
| Sandbox | Restricted Stock Units (RSUs) | |||||
| Business Combination [Line Items] | |||||
| Granted (in shares) | 91,160 | ||||
| Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period, fair value | $ 2,100 | ||||
| Award vesting period (in years) | 4 years |
| X | ||||||||||
- Definition Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|